We are pleased to announce that Sylvain Martel will be joining Tatsuya Suda as a main keynote speaker for the Nano-Net 2008 Conference.
SYLVAIN MARTEL received a Ph.D. degree in Electrical Engineering from McGill University, Institute of Biomedical Engineering, Montréal, Canada, in 1997. Following postdoctoral studies at the Massachusetts Institute of Technology (MIT), he was appointed Research Scientist at the BioInstrumentation Laboratory, Department of Mechanical Engineering at MIT. From Feb. 2001 to Sept. 2004, he had dual appointments at MIT and as Assistant Professor in the Department of Electrical and Computer Engineering, and the Institute of Biomedical Engineering at École Polytechnique de Montréal (EPM), Campus of the University of Montréal, Montréal, Canada. He is currently Associate Professor in the Department of Computer Engineering and the Institute of Biomedical Engineering, and Director of the NanoRobotics Laboratory at EPM that he founded in 2002.Dr. Martel holds the Canada Research Chair (CRC) in Micro/Nanosystem Development, Fabrication and Validation since 2001. He has over 120 refereed publications, several patents, gives several invited presentations annually, and he is an active member in many international committees and organizations worldwide. Dr. Martel’s main expertise is in the field of nanorobotics, micro- and nano-systems, and the development of novel instrumented platforms and a variety of related support technologies targeted mainly for biomedical and bioengineering applications, and nanotechnology. He has a vast experience in electronics, computer engineering, and also worked extensively in biomedical and mechanical engineering.
Presently, Dr. Martel leads a multidisciplinary team involved in research and development of new instrumented platforms mainly for the medical field and in bioengineering, such as 1) development of nano-factories based on a fleet of scientific instruments configured as autonomous miniature robots capable of high throughput screening in biotechnology and autonomous operations at the molecular scale, 2) developmenet of minimally invasive tools based on microdevices propelled in the blood vessels by magnetic gradients generated by Magnetic Resonance Imaging (MRI) systems for tumor targeting and other applications, 3) development of biosensors designed to be navigated through the blood vessels that could potentially be targeted at the brain for non-invasive recording and imaging of brain activities with high spatial resolution, and 4)development of various microsystems using and integrating magnetotactic bacteria as computer controlled functional components for various applications including but not limited to the fast detection of pathogenic bacteria and as bio-carriers for drug delivery in cancer therapy.
~Damira (Nano-Net Webmaster)